Log on / register
Feedback | Support | My details
Pralatrexate, a dihydrofolate reductase inhibitor for the potential treatment of several malignancies
JR Molina
IDrugs 2008 11:508-521
Access to the full text of this article requires a subscription. If you would like information about a personal subscription, please contact info@currentdrugs.com.
Log in Existing subscribers login

Email address
Password 
 
 
Forgotten your password?

Thomson Scientific Journals are available through the BioMed Central platform and feature high quality reviews as well as paper, patent and web alerts to provide accurate and timely information on developments in drug R&D. Covering over 400 scientific meetings per year as well as the most important developments in their subject areas, the Thomson Scientific Journals provide a practical way of staying on top of the latest developments.

IDrugs: The Investigational Drugs Journal saves researchers time and money by providing reports from the most noteworthy and topical meetings happening around the world, offering:

  • Rapid publication with up-to-date coverage
  • Expert evaluations of investigational drugs
  • Reviews highlighting important issues in drug research and analysis

If you are registered and have trouble logging in, email us: info@biomedcentral.com


© 1999-2008 BioMed Central Ltd unless otherwise stated